Detail Information of Exogenous Modulation
General Information of Drug Transporter (DT) | |||||
---|---|---|---|---|---|
DT ID | DTD0528 Transporter Info | ||||
Gene Name | SCN8A | ||||
Transporter Name | Voltage-gated sodium channel alpha Nav1.6 | ||||
Gene ID | |||||
UniProt ID | |||||
Exogenous factors (drugs, dietary constituents, etc.) Modulation of This DT (EGM) | |||||
---|---|---|---|---|---|
Chemical Compound |
|||||
DT Modulation1 |
Cannabidiol results in decreased activity of SCN8A protein | [2] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
1-Methyl-3-isobutylxanthine |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A results in decreased expression of SCN8A mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F results in decreased expression of SCN8A mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SCN8A mRNA | [9] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Benzo(a)pyrene |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Benzo(a)pyrene results in increased methylation of SCN8A 5' UTR | [11] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
Benzo(a)pyrene results in increased methylation of SCN8A exon | [11] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
Benzo(a)pyrene results in increased methylation of SCN8A promoter | [11] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol A |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A results in decreased expression of SCN8A mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
bisphenol F |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F results in decreased expression of SCN8A mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Cadmium Chloride |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cadmium Chloride results in decreased expression of SCN8A mRNA | [12] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Carmustine |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
SCN8A mRNA affects the susceptibility to Carmustine | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
CGP 52608 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
CGP 52608 promotes the reaction RORA protein binds to SCN8A gene | [14] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Copper |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NSC 689534 binds to Copper which results in increased expression of SCN8A mRNA | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
decamethrin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
decamethrin affects the activity of SCN8A protein | [6] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Dexamethasone |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A results in decreased expression of SCN8A mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F results in decreased expression of SCN8A mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
dorsomorphin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SCN8A mRNA | [9] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Estradiol |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Estradiol co-treated with TGFB1 protein results in increased expression of SCN8A mRNA | [16] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Indomethacin |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A results in decreased expression of SCN8A mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F results in decreased expression of SCN8A mRNA | [8] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
NSC 689534 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NSC 689534 binds to Copper which results in increased expression of SCN8A mRNA | [15] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
p-Chloromercuribenzoic Acid |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide results in increased expression of SCN8A mRNA | [9] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
p-Chloromercuribenzoic Acid results in increased expression of SCN8A mRNA | [17] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
prothioconazole |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
prothioconazole results in decreased expression of SCN8A mRNA | [18] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
S-(1,2-dichlorovinyl)cysteine |
3 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
S-(1,2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides which results in increased expression of SCN8A mRNA | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
S-(1,2-dichlorovinyl)cysteine co-treated with Lipopolysaccharides results in increased expression of SCN8A mRNA | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation3 |
S-(1,2-dichlorovinyl)cysteine results in increased expression of SCN8A mRNA | [19] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
sodium arsenite |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
sodium arsenite affects the methylation of SCN8A gene | [20] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
DT Modulation2 |
sodium arsenite results in increased expression of SCN8A mRNA | [21] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Temozolomide |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
SCN8A mRNA affects the susceptibility to Temozolomide | [13] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Valproic Acid |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Valproic Acid results in decreased methylation of SCN8A gene | [22] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Mycotoxins |
|||||
Aflatoxin B1 |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Aflatoxin B1 results in increased methylation of SCN8A gene | [10] | |||
Regulation Mechanism |
Transcription Factor Info | ||||
Approved Drug |
|||||
Melphalan |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Melphalan inhibits the expression of SCN8A | [1] | |||
Cannabidiol |
2 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Cannabidiol inhibits the activity of SCN8A | [2] | |||
Sunitinib |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Sunitinib inhibits the expression of SCN8A | [3] | |||
Tretinoin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tretinoin increases the expression of SCN8A | [4] | |||
Drug in Phase 2 Trial |
|||||
Genistein |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Genistein inhibits the expression of SCN8A | [5] | |||
Natural Product |
|||||
Tobacco Smoke Pollution |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Tobacco Smoke Pollution inhibits the expression of SCN8A | [7] | |||
Pesticide/Insecticide |
|||||
Decamethrin |
1 DT Activity Modulations Related to This Exogenous Factor | Click to Show/Hide the Full List | |||
DT Modulation1 |
Decamethrin affects the activity of SCN8A | [6] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Li and Dr. Fu.